Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Moderated Keynote Chat
ARCH Venture Partners
William N. Hait
Moderated Keynote Chat: Reimagining the Future of R&D Innovation
Johnson & Johnson
A look back at 2018's big developments, trends, non-starters and their implications for 2019
A closer look at some of the influential & interesting financing rounds and the stories behind the science
What are the operational challenges of re-starting a company after a spin-off? Implications for hiring/retaining key employees, portfolio strategy, brand identity? FLX CEO and COO weighs in on the story behind story, 2017 at FLX, and what lessons you can learn from their transition.
A look at the biotech market in Asia, big developments, regulatory updates and business perspectives from those operating in the space
Ascletis’ mission is to become a world-class biotechnology company addressing unmet medical needs in three therapeutic areas: anti-viral, cancer and fatty liver disease, for the patients in China and worldwide.
Led by a management team with deep expertise and a proven track record, we have developed an integrated anti-viral platform covering the entire value chain from discovery and development to manufacturing and commercialization.
An overview of the current biotech landscape in Europe, from financing and talent to trends and latest developments, a discussion to set the stage for Europe CEO 2019
Join an intimate moderated keynote with a visionary R&D leader as he discusses new concepts and trends in R&D innovation and his vision for creating a world without disease.